Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

MDxHealth SA - Ordinary Shares (NQ:MDXH)

2.120 -0.090 (-4.07%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jul 1, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 7,218
Open 2.220
Bid (Size) 2.050 (15)
Ask (Size) 2.850 (12)
Prev. Close 2.210
Today's Range 2.120 - 2.220
52wk Range 1.350 - 3.500
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
MDxHealth Reports Q1-2025 Results
From mdxhealth
Via GlobeNewswire
Mdxhealth to Release First Quarter 2025 Financial Results on May 14
From mdxhealth
Via GlobeNewswire

Performance

YTD
-7.8%
-7.8%
1 Month
-3.6%
-3.6%
3 Month
+45.7%
+45.7%
6 Month
-10.5%
-10.5%
1 Year
-10.2%
-10.2%

More News

Read More
Mdxhealth Announces Fourth Quarter and Full-Year 2024 Financial Results
From mdxhealth
Via GlobeNewswire
Mdxhealth to Present Fourth Quarter and Full Year 2024 Financial Results and Corporate Update on February 26
From mdxhealth
Via GlobeNewswire
Earnings Scheduled For May 14, 2025
Via Benzinga
Earnings Scheduled For February 26, 2025
Via Benzinga
MDxHealth Reports Preliminary Fourth Quarter and Full Year 2024 Revenues and Issues 2025 Revenue Guidance
From mdxhealth
Via GlobeNewswire
MDxHealth to Participate in Piper Sandler Healthcare Conference
From mdxhealth
Via GlobeNewswire
MDxHealth Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2024
From mdxhealth
Via GlobeNewswire
MDxHealth to Present Third Quarter 2024 Financial Results and Corporate Update on November 6
From mdxhealth
Via GlobeNewswire
Dow Surges Over 250 Points; Accenture Earnings Top Views
Via Benzinga
Topics Stocks
Crude Oil Down Over 2%; US Initial Jobless Claims Fall
Via Benzinga
Nasdaq Gains Over 1%; Micron Posts Upbeat Q4 Results
Via Benzinga
Why Telesis Bio Shares Are Trading Higher By Around 110%; Here Are 20 Stocks Moving Premarket
Via Benzinga
MDxHealth Announces Pricing of Offering of Ordinary Shares
From mdxhealth
Via GlobeNewswire
MDxHealth Announces Launch of Offering of Ordinary Shares
From mdxhealth
Via GlobeNewswire
MDXH Stock Earnings: MDxHealth Misses EPS, Beats Revenue for Q2 2024
Via InvestorPlace
MDxHealth Reports Q2 and Half Year 2024 Results
From mdxhealth
Via GlobeNewswire
MDxHealth to Present Second Quarter and First Half 2024 Financial Results and Corporate Update on August 21
From mdxhealth
Via GlobeNewswire
MDxHealth Reports Preliminary Q2 and Half Year 2024 Revenues and Raises 2024 Revenue Guidance
From mdxhealth
Via GlobeNewswire
Mdxhealth Appoints Sanford J. Siegel, M.D. to Board of Directors
From mdxhealth
Via GlobeNewswire
Mdxhealth to Present at Upcoming Investor Conferences
From mdxhealth
Via GlobeNewswire
MDXH Stock Earnings: MDxHealth Misses EPS, Beats Revenue for Q1 2024
Via InvestorPlace
MDxHealth Reports Q1-2024 Results and Announces Growth Capital from OrbiMed
From mdxhealth
Via GlobeNewswire
Mdxhealth Adds Hereditary Prostate Cancer Genetic Test to Prostate Cancer Offering
From mdxhealth
Via GlobeNewswire

Frequently Asked Questions

Is MDxHealth SA - Ordinary Shares publicly traded?
Yes, MDxHealth SA - Ordinary Shares is publicly traded.
What exchange does MDxHealth SA - Ordinary Shares trade on?
MDxHealth SA - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for MDxHealth SA - Ordinary Shares?
The ticker symbol for MDxHealth SA - Ordinary Shares is MDXH on the Nasdaq Stock Market
What is the current price of MDxHealth SA - Ordinary Shares?
The current price of MDxHealth SA - Ordinary Shares is 2.120
When was MDxHealth SA - Ordinary Shares last traded?
The last trade of MDxHealth SA - Ordinary Shares was at 07/01/25 04:00 PM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.